BioMerieux
[WKN: A2DXZH | ISIN: FR0013280286]
Aktienkurse
102,200€ 0,89%
Echtzeit-Aktienkurs BioMerieux
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

QVance Announces Partnership

NextCell Pharma AB* comments on its subsidiary QVance’s partnership with bioMérieux Sweden AB, which aims to strengthen quality control analytics…